Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-DND1 antibody (Catalog #: ARP41198_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
DND1
Reactivité: Humain, Rat
Hôte: Synthetic
BP, WB
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
DND1
(Dead End Homolog 1 (DND1))
Synonymes
dnd Peptide, xde Peptide, Xdead Peptide, rbms4 Peptide, dead-end Peptide, DND1 Peptide, BC034897 Peptide, RBMS4 Peptide, Ter Peptide, DND microRNA-mediated repression inhibitor 1 Peptide, dead end protein homolog 1 pseudogene Peptide, dnd1 Peptide, LOC100349427 Peptide, DND1 Peptide, Dnd1 Peptide
Sujet
DND1 contains 2 RRM (RNA recognition motif) domains. It may play a role during primordial germ cell (PGC) development. However, DND1 does not seem to be essential for PGC migration